Crossmark Global Holdings Inc. increased its stake in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 39.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,531 shares of the medical instruments supplier's stock after purchasing an additional 711 shares during the period. Crossmark Global Holdings Inc.'s holdings in Mettler-Toledo International were worth $3,796,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently made changes to their positions in MTD. Family Firm Inc. purchased a new stake in Mettler-Toledo International during the second quarter worth $25,000. Blue Trust Inc. raised its holdings in Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier's stock worth $34,000 after purchasing an additional 17 shares during the period. Rothschild Investment LLC acquired a new position in shares of Mettler-Toledo International during the 2nd quarter worth approximately $42,000. Itau Unibanco Holding S.A. purchased a new stake in Mettler-Toledo International in the 2nd quarter worth $42,000. Finally, Crewe Advisors LLC lifted its holdings in Mettler-Toledo International by 244.4% during the second quarter. Crewe Advisors LLC now owns 31 shares of the medical instruments supplier's stock valued at $43,000 after purchasing an additional 22 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.
Mettler-Toledo International Trading Up 0.2 %
MTD traded up $2.34 during mid-day trading on Tuesday, hitting $1,252.41. 38,250 shares of the stock were exchanged, compared to its average volume of 133,718. The company has a market cap of $26.57 billion, a PE ratio of 33.70, a PEG ratio of 3.83 and a beta of 1.16. The firm's fifty day moving average is $1,394.23 and its two-hundred day moving average is $1,402.64. Mettler-Toledo International Inc. has a 1-year low of $1,015.29 and a 1-year high of $1,546.93.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts' consensus estimates of $10.00 by $0.21. The firm had revenue of $954.54 million during the quarter, compared to analysts' expectations of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 532.25%. As a group, research analysts anticipate that Mettler-Toledo International Inc. will post 40.34 earnings per share for the current year.
Insider Buying and Selling
In related news, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at $1,044,459.98. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.94% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on MTD. Robert W. Baird lowered their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating on the stock in a report on Monday. Evercore ISI increased their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an "in-line" rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. lifted their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a "neutral" rating in a report on Monday, August 5th. Stifel Nicolaus reduced their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a research note on Monday. Finally, Wells Fargo & Company cut their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating for the company in a report on Monday. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Mettler-Toledo International currently has a consensus rating of "Hold" and an average price target of $1,338.75.
Check Out Our Latest Stock Analysis on Mettler-Toledo International
Mettler-Toledo International Company Profile
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured Articles
Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.